Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program

OBJECTIVE: Obesity is a growing global concern compounded by limited availability of effective treatment options. The SURMOUNT development program aims to evaluate the efficacy and safety of tirzepatide as an adjunct to lifestyle intervention compared with placebo on chronic weight management in adu...

Descripción completa

Detalles Bibliográficos
Autores principales: le Roux, Carel W., Zhang, Shuyu, Aronne, Louis J., Kushner, Robert F., Chao, Ariana M., Machineni, Sriram, Dunn, Julia, Chigutsa, Farai B., Ahmad, Nadia N., Bunck, Mathijs C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107501/
https://www.ncbi.nlm.nih.gov/pubmed/36478180
http://dx.doi.org/10.1002/oby.23612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107501/
https://www.ncbi.nlm.nih.gov/pubmed/36478180
http://dx.doi.org/10.1002/oby.23612

Ejemplares similares